Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147302 | SCV000194675 | pathogenic | Iron accumulation in brain | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004700467 | SCV005204218 | uncertain significance | not specified | 2024-06-20 | criteria provided, single submitter | clinical testing | Variant summary: PLA2G6 c.1754C>T (p.Thr585Ile) results in a non-conservative amino acid change located in the Patatin-like phospholipase domain (IPR002641) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251170 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1754C>T has been reported in the literature in at least one compound heterozygous individual affected with Infantile Neuroaxonal Dystrophy (Morgan_2006). These report(s) do not provide unequivocal conclusions about association of the variant with Infantile Neuroaxonal Dystrophy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 18799783, 16783378). ClinVar contains an entry for this variant (Variation ID: 159747). Based on the evidence outlined above, the variant was classified as uncertain significance. |